Moreover, the re-expression of GAL1R in GAL1R/GAL2R-negative HNSCC cells also suppressed tumor cell proliferation through ERK1/2-mediated actions on cyclin-dependent kinase inhibitors and cyclin D1 [113]. This evidence concerns the gene GALR2 and head and neck squamous cell carcinoma.